Day Traders, Penny Stocks, Stock Options, Futures and Forex

Ingen China Patent is Now Issued and Published


China is Close Target for Oxyview Nasal Cannula Distribution

YUCAIPA, Calif., Oct 1, 2009 (GlobeNewswire via COMTEX) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries announced today that the Company has received notification from its patent attorney, Donn Harms, regarding the publication of the Chinese patent for the Oxyview and the Oxyview Nasal Cannula.
The designated Chinese patent application no. 200710005067.4 was officially issued and published on July 1, 2009 for the cannula gas flow meter referred to as "Oxyview".

The company's pending patents in Japan, Canada, and the European Communities are expected to issue in 2010.

Donn K. Harms is a Registered Patent Attorney also handling business and corporate law matters since 1988, with heavy emphasis on trademarks, copyrights, patents, and licensing matters. Mr. Harms is certified by the San Diego County Bar Association for trademarks, and is a former member of the American Bar Association Committee on Trademark Law for recommendations to the U.S. Congress. His San Diego based firm, American Patent and Trademark Law Center, is a professional association of independent registered patent attorneys and specializes in patent, trademark, copyright and related business and government contract matters with agents and associates throughout the world, including China and Russia, providing various types of domestic and international filing needs for their clients. The firm is registered to practice before the United States Patent & Trademark Office.

"Mr. Harms has been our patent attorney since 1997, and has effectively provided his services that have allowed for several issued patents, domestic and foreign. You could not find a more successful firm and patent attorney than Donn Harms. Our patents provide a higher valuation of our company and additional security to our intellectual property, specifically our new "gravity-independent" technology applied to the Oxyview products, and our "digital transmission" technology applied to our OxyAlert products. The world market for our products includes 600M patients requiring supplementary oxygen and home oxygen therapy. We have recently shown increased sales in the USA with demand of our Oxyview Nasal Cannula products, and we have the company positioned to enter markets in China, Europe, Japan, Canada and Australia for product distribution in early 2010 as an additional revenue stream for Ingen," stated Scott R. Sand, CEO and Chairman of the Board.

Patent and Trademark Attorneys in San Diego

Ingen Technologies,Inc. - Home

The Ingen Technologies, Inc. logo is available at GlobeNewswire, Inc.

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

This news release was distributed by GlobeNewswire, GlobeNewswire - Press Release Distribution - EDGAR Filings - Video News Releases

SOURCE: Ingen Technologies, Inc.


By Staff

CONTACT: CONTACT: Ingen Technologies, Inc.
Christopher A. Wirth
909-790-7180
Ingen Technologies,Inc. - Home

(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.
-0-

INDUSTRY KEYWORD: Healthcare & Medical Services
SUBJECT CODE: MEDICAL
HEALTH
Patents
Health

"Hello,
The Picks that you have provided is really good I shall keep a track of them. Thanks for the article.

Cheers
Ashish

For hot Penny stock picks and daily video alerts visit Hyper Growth Stock | Free Penny Stock Alerts, Penny Stocks Video analysis, Pennystock newsletter, Best Penny Stock Picks & Investor Education "

Ingen product to be unveiled in Germany

Oct 04, 2009 (Inland Valley Daily Bulletin - McClatchy-Tribune Information Services via COMTEX) -- Ingen Technologies' main product, Oxyview Nasal Cannula, will be introduced at a November event in Germany called Medica, where 135,000 people from 100 countries will attend and gather information on "future trends in in-patient and out-patient care," the company said Thursday.
The introduction will be made by Emergo Group, which is developing an ISO quality management system and technical file for Ingen in Europe.

This will help make Yucaipa-based Ingen compliant to sell Oxyview Nasal Cannula in European countries, according to a news release.

Oxyview -- a respiratory device that utilizes gas flow-meter technology to deliver supplemental oxygen to hospital patients -- will also be introduced in January by Emergo Group at the Arab Health Exhibition and Congress, the "largest health-care exhibition in the Middle East, and the second largest in the world," the release says.

In addition, Ingen "is currently negotiating with an Australian distributor to market and sell the Oxyview Nasal Cannula," the release says.

Emergo will help Ingen get compliant in that market, the release says.

Ingen said it has attracted "interested acquirers," but so far nothing has come about. An investment banker reportedly is helping the company solicit itself.

The company reported $8.1 million in losses over the last three fiscal years, and it had a $10.6 million deficit as of May 31 and "must decrease its cash burn rate" to grow the

business, according to its annual report. The basics

Ingen Technologies Inc. (Pink Sheets: IGNT.PK) is a medical device manufacturer that develops medical respiratory and medical diagnostic technologies and products. The company specializes in gas flow-meter technology and wireless digital data transfer of gas-flow-rate processing.

Headquarters:

35193 Avenue A, Yucaipa

(909) 790-7180; Ingen Technologies,Inc. - Home

On the market

Monday's open: $0.0024

Friday's close: $0.0062

Market capitalization: $3.3 million



To see more of the Inland Valley Daily Bulletin or to subscribe to the
newspaper, go to Home - DailyBulletin.com. Copyright (c) 2009, Inland
Valley Daily Bulletin, Calif. Distributed by McClatchy-Tribune Information
Services. For reprints, email tmsreprints@permissionsgroup.com, call
800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The
Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.
Matt Wrye

Copyright (C) 2009, Inland Valley Daily Bulletin, Calif.
-0-

SUBJECT CODE: IV

IGNT 9 30 09

Pinnacle Digest: Looking For Opinions On Ingen Technologies' Latest News

Oct 06, 2009 (M2 PRESSWIRE via COMTEX) -- www.******************* is a performance-driven online financial magazine and social network with a proven track record. After yesterday's news from Ingen Technologies, Inc. (Pink Sheets:IGNT) announcing that Yesterday's Senior Magazine October issue was distributed to 180,000 seniors in California and Texas combined, our team is inviting all shareholders to their exclusive investor controlled forum. Our staff and members have requested that all Ingen shareholders join our community and share their thoughts on the company, its development and future outlook. One of the most important aspects when we research for new investments is to understand the sentiment of the current shareholders; that is why we have released this announcement - we want to know your opinion.
Join The Ingen Investor Discussion Here: http://www.*******************/company/ignt

Join ******************* to

Find out if Ingen makes it as a Pinnacle Featured Company,

Chat with other shareholders invested in Ingen,

Explain to our investor community what differentiates this company,

Connect with investors and professionals in the equity markets,

Meet the thousands of investors who have already become members of the Pinnacle community.

******************* is an investment club comprised of over 15,000 members. We use all of our member's insight when selecting our next investment opportunity. Your membership is free - join today.

******************* has no vested interest in the company mentioned herein. The company mentioned in this release has not compensated ******************* in any form to disseminate this release.

This source of information is from an unbiased perspective. If you wish to become a member of www.******************* you will be gaining access to articles similar to this one and many other useful services we know you will find valuable. Keeping you educated and up-to-date with the market is one of our main purposes. Our approach in achieving this goal and our ability to consistently deliver high quality investment material is what defines our business model.

This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.

All material herein was prepared by ******************* (Pinnacle Digest) based upon information believed to be reliable. The information contained herein is not guaranteed by ******************* to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. ******************* is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. ******************* may receive compensation in cash or shares from independent third parties or from the companies mentioned.

******************* will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and ******************* undertakes no obligation to update such statements.

CONTACT: Pinnacle Digest WWW: http://www.*******************

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.




(C)1994-2009 M2 COMMUNICATIONS
-0-

Ingen Hits Senior Sector Through Today's Senior Publication


Ingen Stocks-Up Oxyview Nasal Cannula Supply

YUCAIPA, Calif., Oct 5, 2009 (GlobeNewswire via COMTEX) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that Today's Senior Magazine October issue was distributed to 180,000 seniors in California and Texas combined.
The Company has a full-page editorial and a full-page color advertisement of the new Oxyview Nasal Cannula in the October 2009 issue of Today's Senior Magazine. Today's Senior Magazine -- a senior magazine that provides important information, plus local and national products and services for people fifty and over, is one of the most read and talked about senior publications in California and Texas.

The Company is prepared to manufacture another 100,000 Oxyview Nasal Cannulas and has recently sold 50,000 Oxyview Nasal Cannulas in the past 60 days. "The patients have shown that they want the new Oxyview Nasal Cannula. Our inventory is well stocked, and we have worked out the bugs in our shipping and receiving while we maintain FDA and ISO compliance," stated Scott R. Sand, Chief Executive Officer and Chairman. Sand further stated, "Our engineering and management team are reviewing our manufacturing processes to meet projected annual inventory of 15M Oxyview Nasal Cannulas or approximately $86M in product sales. This is not unrealistic when you consider how Ingen has positioned the product, secured patents and intellectual property and has brought in the right groups to move product into the USA and globally."

Senior Health : Ingen Technologies, Inc.

Ingen Technologies,Inc. - Home

The Ingen Technologies, Inc. logo is available at GlobeNewswire, Inc.

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

This news release was distributed by GlobeNewswire, GlobeNewswire - Press Release Distribution - EDGAR Filings - Video News Releases

SOURCE: Ingen Technologies, Inc.


By Staff

CONTACT: CONTACT: Ingen Technologies, Inc.
Christopher A. Wirth
909-790-7180
Ingen Technologies,Inc. - Home

(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.
-0-

INDUSTRY KEYWORD: Healthcare & Medical Services
SUBJECT CODE: MEDICAL
HEALTH
PUBLISHING
Product Services Announcement
Health

Oxyview offers cost savings for the entire global oxygen industry. "It has been 90 days since the 36-month cap on oxygen equipment rental went into effect in the USA. Most providers have found a way to stay in business; although the industry is only faced with the initial challenge associated with revenue reduction and lower reimbursement. Oxyview will play a small role in a huge and growing industry by eliminating unnecessary service calls to the home oxygen patient, and easily diagnosing equipment malfunction that could lead to malpractice suits. Oxyview stands alone in the in-line gravity independent flow-meter market, with potential sales of $30M annually, and savings in the industry of 10 times that amount. One Oxyview costs less than a single service call," Stated Scott Sand, CEO and Chairman of Ingen Technologies.

i look for this to get real hot and some poss news at close

Rumor of news comeing out after the close!!! Good time to get in while the price is on the dip. Stock moves on news so look for price increases and take ur profits

IGNT,,RSI on steep dip[ need macd line to stay above signal, price dropped -0.0002 bids are building at .004 .i see it poss coming out of the hole

YUCAIPA, Calif., Oct. 8, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading Global Medical Device manufacturer focused in the $ 4 Billion Respiratory Market for the growing ageing and emerging markets for Home (DME), Hospital and Aviation Industries announced today that the company has signed a national 5 month campaign with The Money Channel and American Scene Radio program to reach millions of wealthy investors.


Related Quotes
Symbol Price Change
IGNT.PK 0.0038 -0.0004


{"s" : "ignt.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}
The Money Channel offers Ingen major exposure to the investment world. The program includes 12 Investor Showcase Radio segments on the American Scene radio program from now through March 31, 2010. Ingen will also be present at the World Money Show in February-2010 which will be a televised segment on Fox Business Television.



The Money Channel is one of the most successful, national Money-talk Radio programs in America. "Steve Crowley's American Scene" was launched from the Disney/MGM Radio Studios at the Walt Disney World Resort in June 1990. American Scene attracts a larger and larger radio audience every month from coast to coast. The Money Channel recently added Boston and Atlanta affiliates to our tremendous national lineup of stations. Today, The Money Channel has a national base of 3,000,000 listeners on a three-hour daily radio broadcast through the mighty IRN/USA Radio Network affiliates, plus other affiliates, and they have a growing listening audience on the Internet worldwide. This is the primary destination for Steve Crowley's insights and advice in the financial world. Plus Steve interviews all the top experts, analysts, money managers and authors covering stocks, investments, business, the economy and trends, Small-Cap CEOs and much more. More than 200 Financial "Stars" are interviewed in constant rotation....from Steve Forbes to Tobin Smith to Beth Dater to Joe Battipaglia. No other Money-talk Radio Program in America even comes close to this level of credible content.



"I have worked with Steve Crowley over the past several years, and The Money Channel and American Scene Radio have been very effective in the ability to introduce Ingen Technologies to a large group of wealthy investors. Ingen is performing very well with sales, operations, and projected growth trends. The company is at its reflex point, and projections for 2010 include revenues over $10M, several new Oxyview products, a decrease in manufacturing costs and an increase in margins, as well as an increase in earnings," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.